Business Context and Reporting Period
This Form 8-K, dated March 11, 2013, reports on Cactus Ventures, Inc. (the "Company") and its acquisition activities involving Actinium Pharmaceuticals, Inc. ("Actinium"). The filing details the closing of a second share exchange agreement on March 11, 2013, following an initial agreement in December 2012.
Key Financial Metrics and Transaction Details
The filing focuses on equity transactions rather than operational financial metrics such as revenue or cash flow. Key transaction data includes:
- Shares Acquired: Cactus acquired 22,055,225 additional shares of Actinium in this transaction.
- Consideration Issued: Cactus issued 7,344,390 shares of its common stock to Actinium shareholders.
- Ownership Stake: The new shares represent 36% of Actinium's issued and outstanding equity. Combined with the prior transaction, Cactus now holds approximately 55.5% (34,995,211 shares) of Actinium.
- Financial Statements: The filing references audited financial statements for Actinium for years ended December 31, 2011 and 2010, and unaudited interim statements for periods ended September 30, 2012 and 2011, but does not list specific revenue, profit, or debt figures in the text.
Material Changes Versus Prior Period
As of March 11, 2013, Cactus increased its ownership in Actinium from 21% (acquired in December 2012) to approximately 55.5%. This transaction solidified the control of former Actinium shareholders over Cactus, resulting in the appointment of Actinium's directors to Cactus's Board and Actinium's officers to Cactus's executive roles.
Guidance, Outlook, and Risks
Outlook: The Company intends to continue exchanging its common stock for shares of Actinium held by remaining shareholders to further consolidate ownership.
Regulatory Context: The shares were issued in a private transaction relying on exemptions under Section 4(2) of the Securities Act and Rule 506 of Regulation D, based on investor representations as "accredited investors."
Risks/Contingencies: The filing does not explicitly detail operational risks or contingencies beyond the standard incorporation of the Share Exchange Agreement by reference.
Investor Verification Checklist
- Verify the total number of outstanding shares for both Cactus Ventures and Actinium to confirm the exact percentage ownership post-transaction.
- Review the attached Audited Consolidated Financial Statements (Exhibit 99.1) and Unaudited Interim Statements (Exhibit 99.2) for Actinium's actual revenue, cash flow, and debt levels, as these are not summarized in the text.
- Examine the Unaudited Pro Forma Combined Financial Information (Exhibit 99.3) to understand the combined financial position of the entities.
- Confirm the terms of the "Second Exchange Agreement" (Exhibit 10.1) for any future obligations or conditions regarding the remaining Actinium shares.